company background image
600285 logo

Henan Lingrui Pharmaceutical SHSE:600285 Stock Report

Last Price

CN¥25.09

Market Cap

CN¥14.1b

7D

1.0%

1Y

62.1%

Updated

15 Jun, 2024

Data

Company Financials +

Henan Lingrui Pharmaceutical Co., Ltd.

SHSE:600285 Stock Report

Market Cap: CN¥14.1b

Henan Lingrui Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Henan Lingrui Pharmaceutical
Historical stock prices
Current Share PriceCN¥25.09
52 Week HighCN¥26.89
52 Week LowCN¥14.30
Beta0.31
1 Month Change0.12%
3 Month Change20.63%
1 Year Change62.08%
3 Year Change164.66%
5 Year Change195.18%
Change since IPO699.44%

Recent News & Updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Recent updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Shareholder Returns

600285CN PharmaceuticalsCN Market
7D1.0%-1.1%0.06%
1Y62.1%-12.5%-16.1%

Return vs Industry: 600285 exceeded the CN Pharmaceuticals industry which returned -12.5% over the past year.

Return vs Market: 600285 exceeded the CN Market which returned -16.1% over the past year.

Price Volatility

Is 600285's price volatile compared to industry and market?
600285 volatility
600285 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 600285 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600285's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19922,530Wei Xiongwww.lingrui.com

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others.

Henan Lingrui Pharmaceutical Co., Ltd. Fundamentals Summary

How do Henan Lingrui Pharmaceutical's earnings and revenue compare to its market cap?
600285 fundamental statistics
Market capCN¥14.15b
Earnings (TTM)CN¥614.24m
Revenue (TTM)CN¥3.43b

23.0x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600285 income statement (TTM)
RevenueCN¥3.43b
Cost of RevenueCN¥925.29m
Gross ProfitCN¥2.51b
Other ExpensesCN¥1.89b
EarningsCN¥614.24m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.09
Gross Margin73.04%
Net Profit Margin17.90%
Debt/Equity Ratio1.0%

How did 600285 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

73%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.